๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacotherapy of anxious disorders

โœ Scribed by Michel Bourin; Olivier Lambert

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
162 KB
Volume
17
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

โœฆ Synopsis

Abstract

The present paper is a review of the treatment of anxious disorders by the current pharmaceutical medications; a short epidemiological survey is given for anxious disorders including: general anxiety disorder, panic disorder, obsessive compulsive disorder, social anxiety and postโ€traumatic stress disorder. For all these disorders there are proposals of treatment built on literature data mainly on metaโ€analysis as well on personal experience. Copyright ยฉ 2002 John Wiley & Sons, Ltd.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacotherapy in personality disorder
Pharmacotherapy in personality disorder
โœ Simon Nicholson ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 540 KB

Personality disorders pose a major therapeutic challenge in psychiatry. However, a substantial body of research suggests that various pharmacological agents, especially low-dose neuroleptics, may be useful against affective, cognitive and behavioural symptoms occurring in these patients. It is propo

Rational pharmacotherapy of gastrointest
Rational pharmacotherapy of gastrointestinal motility disorders
โœ P. Demol; H. -J. Ruoff; T. R. Weihrauch ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 790 KB

Nervous control of gastrointestinal motility is extremely complex, is regulated by the enteric system, the "brain of the gut", and modulated by extrinsic nerves. This system with its multiplicity of transmitters and receptors does not always allow a clear interpretation of experimental data, especia

Pharmacotherapy for obsessive-compulsive
Pharmacotherapy for obsessive-compulsive disorder
โœ Darin D. Dougherty; Scott L. Rauch; Michael A. Jenike ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB

## Abstract Pharmacotherapeutic options for obsessiveโ€compulsive disorder (OCD) have expanded over the past halfโ€century since medications were first found to be effective for the treatment of OCD. Currently, the serotonin reuptake inhibitors (SRIs) represent the firstโ€line pharmacotherapy for OCD.

Advances in pharmacotherapy for pediatri
Advances in pharmacotherapy for pediatric anxiety disorders
โœ Moira Rynn; Anthony Puliafico; Charlotte Heleniak; Pranav Rikhi; Kareem Ghalib; ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 138 KB

Pediatric anxiety disorders are prevalent, chronic, and often lead to significant impaired functioning that impacts both short-and long-term outcomes for children and adolescents. Treatment options include pharmacotherapy and psychosocial interventions. This presentation will review treatment advanc